HUNTER JACQUES: Open Payments
NPI 1326529041 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 60 payments from 12 companies in 2025. Trend: 2023 $205 · 2024 $774 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 12 | $203 |
| ABBVIE INC. | 19 | $197 |
| Phathom Pharmaceuticals, Inc. | 7 | $126 |
| Regeneron Healthcare Solutions, Inc. | 4 | $121 |
| Celltrion USA Inc. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $60 |
| Janssen Biotech, Inc. | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $40 |
Products named: IBSRELA, DUPIXENT, VOQUEZNA, CREON, VEGZELMA, ENTYVIO, TREMFYA, RINVOQ.
Industry payments across SC — which companies pay providers there.
